{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,30]],"date-time":"2025-11-30T13:44:45Z","timestamp":1764510285013,"version":"build-2065373602"},"reference-count":58,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2005,12,1]],"date-time":"2005-12-01T00:00:00Z","timestamp":1133395200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,12,1]],"date-time":"2005-12-01T00:00:00Z","timestamp":1133395200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,4,10]],"date-time":"2015-04-10T00:00:00Z","timestamp":1428624000000},"content-version":"vor","delay-in-days":3417,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["bbmt.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biology of Blood and Marrow Transplantation"],"published-print":{"date-parts":[[2005,12]]},"DOI":"10.1016\/j.bbmt.2005.08.033","type":"journal-article","created":{"date-parts":[[2005,12,13]],"date-time":"2005-12-13T07:27:37Z","timestamp":1134458857000},"page":"1022-1030","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Cytoprotection by Amifostine during Autologous Stem Cell Transplantation for Advanced Refractory Hematologic Malignancies"],"prefix":"10.1016","volume":"11","author":[{"given":"Don A.","family":"Gabriel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas C.","family":"Shea","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan S.","family":"Serody","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dominic T.","family":"Moore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suzanne L.","family":"Kirby","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donald","family":"Harvey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carol","family":"Krasnov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbmt.2005.08.033_bib1","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1046\/j.1365-2036.2003.01784.x","article-title":"Oral and intestinal mucositis\u2014causes and possible treatments","volume":"18","author":"Duncan","year":"2003","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.bbmt.2005.08.033_bib2","first-page":"21","article-title":"A biological approach to mucositis","volume":"2","author":"Sonis","year":"2004","journal-title":"J Support Oncol"},{"key":"10.1016\/j.bbmt.2005.08.033_bib3","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S1085-5629(97)80015-6","article-title":"Oral cavity complications of bone marrow transplantation","volume":"16","author":"Eisen","year":"1997","journal-title":"Semin Cutan Med Surg"},{"key":"10.1016\/j.bbmt.2005.08.033_bib4","first-page":"1493","article-title":"Patterns of mucositis and pain in patients receiving preparative chemotherapy and bone marrow transplantation","volume":"20","author":"McGuire","year":"1993","journal-title":"Oncol Nurs Forum"},{"key":"10.1016\/j.bbmt.2005.08.033_bib5","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S1083-8791(03)00204-0","article-title":"An expanded phase I\/II trial of cyclophosphamide, etoposide, and carboplatin plus total body irradiation with autologous marrow or stem cell support for patients with hematologic malignancies","volume":"9","author":"Shea","year":"2003","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2005.08.033_bib6","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1046\/j.1365-2141.2000.02202.x","article-title":"Prospective evaluation of oral mucositis in patients receiving myeloablative conditioning regimens and haemopoietic progenitor rescue","volume":"110","author":"Wardley","year":"2000","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bbmt.2005.08.033_bib7","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1002\/1097-0142(19930901)72:5<1612::AID-CNCR2820720520>3.0.CO;2-Q","article-title":"A longitudinal study of oral ulcerative mucositis in bone marrow transplant recipients","volume":"72","author":"Woo","year":"1993","journal-title":"Cancer"},{"key":"10.1016\/j.bbmt.2005.08.033_bib8","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1081\/CNV-120002497","article-title":"Defining clinically meaningful outcomes in the evaluation of new treatments for oral mucositis","volume":"20","author":"Bellm","year":"2002","journal-title":"Cancer Invest"},{"key":"10.1016\/j.bbmt.2005.08.033_bib9","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/0304-3959(94)00256-E","article-title":"The factorial structure and stability of the McGill Pain Questionnaire in patients experiencing oral mucositis following bone marrow transplantation","volume":"62","author":"Donaldson","year":"1995","journal-title":"Pain"},{"key":"10.1016\/j.bbmt.2005.08.033_bib10","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1097\/00002820-199812000-00002","article-title":"Acute oral pain and mucositis in bone marrow transplant and leukemia patients","volume":"21","author":"McGuire","year":"1998","journal-title":"Cancer Nurs"},{"key":"10.1016\/j.bbmt.2005.08.033_bib11","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1081\/CNV-120005902","article-title":"The 20 item oral mucositis index","volume":"20","author":"McGuire","year":"2002","journal-title":"Cancer Invest"},{"key":"10.1016\/j.bbmt.2005.08.033_bib12","doi-asserted-by":"crossref","first-page":"2469","DOI":"10.1002\/1097-0142(19920515)69:10<2469::AID-CNCR2820691015>3.0.CO;2-W","article-title":"Clinical assessment scale for the rating of oral mucosal changes associated with bone marrow transplantation. Development of an oral mucositis index","volume":"69","author":"Schubert","year":"1992","journal-title":"Cancer"},{"key":"10.1016\/j.bbmt.2005.08.033_bib13","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/S0964-1955(96)00026-7","article-title":"Quantitative scale of oral mucositis associated with autologous bone marrow transplantation","volume":"32B","author":"Tardieu","year":"1996","journal-title":"Eur J Cancer B Oral Oncol"},{"key":"10.1016\/j.bbmt.2005.08.033_bib14","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1111\/j.1754-4505.1990.tb00795.x","article-title":"A scoring system for the quantitative evaluation of oral mucositis during bone marrow transplantation","volume":"10","author":"Walsh","year":"1990","journal-title":"Spec Care Dentist"},{"key":"10.1016\/j.bbmt.2005.08.033_bib15","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1053\/sonc.2002.37367","article-title":"The potential of amifostine in high-dose chemotherapy and autologous hematopoietic stem cell transplantation","volume":"29","author":"Phillips","year":"2002","journal-title":"Semin Oncol"},{"key":"10.1016\/j.bbmt.2005.08.033_bib16","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1053\/j.seminoncol.2003.11.040","article-title":"The effect of oral mucositis on morbidity and mortality in bone marrow transplant","volume":"30","author":"Gabriel","year":"2003","journal-title":"Semin Oncol"},{"key":"10.1016\/j.bbmt.2005.08.033_bib17","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1200\/JCO.1996.14.7.2101","article-title":"Amifostine pretreatment for protection against cyclophosphamide-induced and cisplatin-induced toxicities","volume":"14","author":"Kemp","year":"1996","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2005.08.033_bib18","doi-asserted-by":"crossref","first-page":"3339","DOI":"10.1200\/JCO.2000.18.19.3339","article-title":"Phase III randomized trial of amifostine as a radioprotector in head and neck cancer","volume":"18","author":"Brizel","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2005.08.033_bib19","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/sj.bmt.1700717","article-title":"Long-term engraftment failure after marrow ablation and autologous hematopoietic reconstitution","volume":"19","author":"Bentley","year":"1997","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2005.08.033_bib20","doi-asserted-by":"crossref","first-page":"3776","DOI":"10.1200\/JCO.1999.17.12.3776","article-title":"Ifosfamide, carboplatin, and etoposide","volume":"17","author":"Moskowitz","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2005.08.033_bib21","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1200\/JCO.1994.12.6.1169","article-title":"ESHAP\u2014an effective chemotherapy regimen in refractory and relapsing lymphoma","volume":"12","author":"Velasquez","year":"1994","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2005.08.033_bib22","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1182\/blood.V71.1.117.117","article-title":"Effective salvage therapy for lymphoma with cisplatin in combination with high-dose Ara-C and dexamethasone (DHAP)","volume":"71","author":"Velasquez","year":"1988","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2005.08.033_bib23","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1002\/(SICI)1097-0142(19990515)85:10<2103::AID-CNCR2>3.0.CO;2-0","article-title":"Validation of a new scoring system for the assessment of clinical trial research of oral mucositis induced by radiation or chemotherapy","volume":"85","author":"Sonis","year":"1999","journal-title":"Cancer"},{"key":"10.1016\/j.bbmt.2005.08.033_bib24","unstructured":"Cancer Therapy Evaluation Program: Common Toxicity Criteria, Version 2.0, DCTD, NCI, NIH, DHHS. March 1998. Available at:http:\/\/ctep.cancer.gov\/reporting\/ctc.html. Accessed Sep 6,2005."},{"key":"10.1016\/j.bbmt.2005.08.033_bib25","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1054\/bjoc.2000.1611","article-title":"A randomized trial of amifostine in patients with high-dose VIC chemotherapy plus autologous blood stem cell transplantation","volume":"84","author":"Hartmann","year":"2001","journal-title":"Br J Cancer"},{"key":"10.1016\/j.bbmt.2005.08.033_bib26","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1097\/00000421-200008000-00019","article-title":"Pilot trial of cytoprotection with amifostine given with high-dose chemotherapy and autologous peripheral blood stem cell transplantation","volume":"23","author":"Chauncey","year":"2000","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.bbmt.2005.08.033_bib27","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S0360-3016(01)02683-9","article-title":"Prophylactic use of amifostine to prevent radiochemotherapy-induced mucositis and xerostomia in head-and-neck cancer","volume":"52","author":"Antonadou","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.bbmt.2005.08.033_bib28","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1038\/sj.bmt.1703757","article-title":"Amifostine reduces mucosal damage after high-dose melphalan conditioning and autologous peripheral blood progenitor cell transplantation for patients with multiple myeloma","volume":"30","author":"Thieblemont","year":"2002","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2005.08.033_bib29","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1046\/j.1365-2141.2000.02149.x","article-title":"Amifostine can reduce mucosal damage after high-dose melphalan conditioning for peripheral blood progenitor cell autotransplant","volume":"110","author":"Capelli","year":"2000","journal-title":"Br J Haematol"},{"issue":"suppl 1","key":"10.1016\/j.bbmt.2005.08.033_bib30","first-page":"404b","article-title":"Amifostine pretreatment for protection against melphalan plus busulfan-induced toxicity in high-dose therapy for multiple myeloma patients","volume":"94","author":"Patriarca","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2005.08.033_bib31","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1080\/00365549309169668","article-title":"Failure of clindamycin to influence the course of severe oromucositis associated with streptococcal bacteraemia in allogeneic bone marrow transplant recipients","volume":"25","author":"Donnelly","year":"1993","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.bbmt.2005.08.033_bib32","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1002\/cncr.11671","article-title":"The burdens of cancer therapy. Clinical and economic outcomes of chemotherapy-induced mucositis","volume":"98","author":"Elting","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.bbmt.2005.08.033_bib33","first-page":"120","article-title":"Oral complications in bone marrow transplantation patients","volume":"30","author":"Garfunkel","year":"1994","journal-title":"Isr J Med Sci"},{"key":"10.1016\/j.bbmt.2005.08.033_bib34","first-page":"290","article-title":"Oral mucositis complicating chemotherapy and\/or radiotherapy","volume":"51","author":"Kostler","year":"2001","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.bbmt.2005.08.033_bib35","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1086\/322595","article-title":"Risk factors for anaerobic bloodstream infections in bone marrow transplant recipients","volume":"33","author":"Lark","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.bbmt.2005.08.033_bib36","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0163-4453(97)91545-0","article-title":"Changes in the oral streptococcal flora of children undergoing allogeneic bone marrow transplantation","volume":"35","author":"Lucas","year":"1997","journal-title":"J Infect"},{"key":"10.1016\/j.bbmt.2005.08.033_bib37","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1002\/(SICI)1097-0142(19980601)82:11<2275::AID-CNCR25>3.0.CO;2-Q","article-title":"The impact of mucositis on alpha-hemolytic streptococcal infection in patients undergoing autologous bone marrow transplantation for hematologic malignancies","volume":"82","author":"Ruescher","year":"1998","journal-title":"Cancer"},{"key":"10.1016\/j.bbmt.2005.08.033_bib38","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1080\/1024533021000037216","article-title":"Oral mucositis","volume":"7","author":"Alvarado","year":"2002","journal-title":"Hematology"},{"key":"10.1016\/j.bbmt.2005.08.033_bib39","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1038\/sj.bmt.1702447","article-title":"Mucosal barrier injury: biology, pathology, clinical counterparts and consequences of intensive treatment for haematological malignancy: an overview","volume":"25","author":"Blijlevens","year":"2000","journal-title":"Bone Marrow Transplant"},{"issue":"suppl 2","key":"10.1016\/j.bbmt.2005.08.033_bib40","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1038\/sj.bmt.1702863","article-title":"Mucositis associated with stem cell transplantation","volume":"27","author":"Stiff","year":"2001","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2005.08.033_bib41","doi-asserted-by":"crossref","first-page":"185","DOI":"10.2165\/00002018-199309030-00004","article-title":"Cancer therapy and oral mucositis. An appraisal of drug prophylaxis","volume":"9","author":"Verdi","year":"1993","journal-title":"Drug Saf"},{"key":"10.1016\/j.bbmt.2005.08.033_bib42","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1067\/moe.2002.126018","article-title":"The role of salivary function in modulating chemotherapy-induced oropharyngeal mucositis","volume":"94","author":"Epstein","year":"2002","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"10.1016\/j.bbmt.2005.08.033_bib43","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S1368-8375(97)00053-5","article-title":"Mucositis as a biological process","volume":"34","author":"Sonis","year":"1998","journal-title":"Oral Oncol"},{"key":"10.1016\/j.bbmt.2005.08.033_bib44","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1177\/154411130201300502","article-title":"The biologic role for nuclear factor-kappaB in disease and its potential involvement in mucosal injury associated with anti-neoplastic therapy","volume":"13","author":"Sonis","year":"2002","journal-title":"Crit Rev Oral Biol Med"},{"key":"10.1016\/j.bbmt.2005.08.033_bib45","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1126\/science.1060191","article-title":"Endothelial apoptosis as the primary lesion initiating intestinal radiation damage in mice","volume":"293","author":"Paris","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.bbmt.2005.08.033_bib46","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/S1473-3099(03)00668-6","article-title":"Antimicrobial therapy to prevent or treat oral mucositis","volume":"3","author":"Donnelly","year":"2003","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.bbmt.2005.08.033_bib47","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1038\/sj.onc.1203413","article-title":"The cytoprotective aminothiol WR1065 activates p21waf-1 and down regulates cell cycle progression through a p53-dependent pathway","volume":"19","author":"North","year":"2000","journal-title":"Oncogene"},{"key":"10.1016\/j.bbmt.2005.08.033_bib48","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/S0360-3016(01)02820-6","article-title":"Activation of the nuclear transcription factor kappaB (NFkappaB) and differential gene expression in U87 glioma cells after exposure to the cytoprotector amifostine","volume":"53","author":"Kataoka","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.bbmt.2005.08.033_bib49","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1016\/S0891-5849(01)00554-8","article-title":"Activation of NFkappaB and MnSOD gene expression by free radical scavengers in human microvascular endothelial cells","volume":"30","author":"Murley","year":"2001","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.bbmt.2005.08.033_bib50","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1081\/CNV-100000145","article-title":"Economic analysis of amifostine as adjunctive support for patients with advanced head and neck cancer","volume":"19","author":"Bennett","year":"2001","journal-title":"Cancer Invest"},{"key":"10.1016\/j.bbmt.2005.08.033_bib51","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1200\/JCO.2001.19.8.2201","article-title":"Oral mucositis and the clinical and economic outcomes of hematopoietic stem-cell transplantation","volume":"19","author":"Sonis","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2005.08.033_bib52","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/0964-1955(94)90059-0","article-title":"Prevention of oral mucositis in patients treated with high-dose chemotherapy and bone marrow transplantation","volume":"30B","author":"Borowski","year":"1994","journal-title":"Eur J Cancer B Oral Oncol"},{"key":"10.1016\/j.bbmt.2005.08.033_bib53","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/S0360-3016(97)00076-X","article-title":"Low energy helium-neon laser in the prevention of oral mucositis in patients undergoing bone marrow transplant","volume":"38","author":"Cowen","year":"1997","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.bbmt.2005.08.033_bib54","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1089\/104454702320901107","article-title":"NASA light-emitting diodes for the prevention of oral mucositis in pediatric bone marrow transplant patients","volume":"20","author":"Whelan","year":"2002","journal-title":"J Clin Laser Med Surg"},{"key":"10.1016\/j.bbmt.2005.08.033_bib55","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/sj.bmt.1703394","article-title":"A phase I\/II double-blind, placebo-controlled study of recombinant human interleukin-11 for mucositis and acute GVHD prevention in allogeneic stem cell transplantation","volume":"29","author":"Antin","year":"2002","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2005.08.033_bib56","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S1079-2104(99)70034-X","article-title":"GM-CSF mouthrinses in the treatment of severe oral mucositis","volume":"88","author":"Bez","year":"1999","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"10.1016\/j.bbmt.2005.08.033_bib57","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1200\/JCO.2003.10.079","article-title":"Randomized phase I trial of recombinant human keratinocyte growth factor plus chemotherapy","volume":"21","author":"Meropol","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2005.08.033_bib58","doi-asserted-by":"crossref","first-page":"2590","DOI":"10.1056\/NEJMoa040125","article-title":"Palifermin for oral mucositis after intensive therapy for hematologic cancers","volume":"351","author":"Spielberger","year":"2004","journal-title":"N Engl J Med"}],"container-title":["Biology of Blood and Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879105005690?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879105005690?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T14:24:58Z","timestamp":1761056698000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1083879105005690"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,12]]},"references-count":58,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2005,12]]}},"alternative-id":["S1083879105005690"],"URL":"https:\/\/doi.org\/10.1016\/j.bbmt.2005.08.033","relation":{},"ISSN":["1083-8791"],"issn-type":[{"type":"print","value":"1083-8791"}],"subject":[],"published":{"date-parts":[[2005,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cytoprotection by Amifostine during Autologous Stem Cell Transplantation for Advanced Refractory Hematologic Malignancies","name":"articletitle","label":"Article Title"},{"value":"Biology of Blood and Marrow Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbmt.2005.08.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 American Society for Blood and Marrow Transplantation. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}